Genomic factors shaping codon usage across the Saccharomycotina subphylum.

Autor: Zavala, Bryan¹ (AUTHOR), Dineen, Lauren¹ (AUTHOR), Fisher, Kaitlin J^2,3 (AUTHOR), Opulente, Dana A^4,5 (AUTHOR), Harrison, Marie-Claire^6,7 (AUTHOR), Wolters, John F⁵ (AUTHOR), Shen, Xing-Xing⁸ (AUTHOR), Zhou, Xiaofan⁹ (AUTHOR), Groenewald, Marizeth¹⁰ (AUTHOR), Hittinger, Chris Todd⁵ (AUTHOR), Rokas, Antonis^6,7 (AUTHOR), LaBella, Abigail Leavitt^1,11 (AUTHOR) alabell3@charlotte.edu

Publikováno v: G3: Genes | Genomes | Genetics. Nov2024, Vol. 14 Issue 11, p1-12. 12p.

Mental Health Providers' Perspectives on What Helps and Hinders in Psychotherapy for Autistic Adults with Co-occurring Mental Health Problems.

Autor: Jubenville-Wood, Theresa¹, Nicholas, David B.¹ nicholas@ucalgary.ca, Weiss, Jonathan², Cairns, Sharon¹

Publikováno v: Journal of Autism & Developmental Disorders. Nov2024, Vol. 54 Issue 11, p4311-4324. 14p.

Catalytic CO 2 Desorption from MEA Solution of Al-FeOOH Composite Catalysts' Desorption Performance, Structure–Activity Relationship, and New Mechanism.

Autor: Shi, Huancong^1,2 (AUTHOR) 223362039@st.usst.edu.cn, Lv, Junge^1,2 (AUTHOR) haoranzhanggo@163.com, Feng, Yongcheng³ (AUTHOR) fengyc_007@163.com, Zhang, Haoran¹ (AUTHOR) xzb412@usst.edu.cn, Xiong, Zhibo¹ (AUTHOR) alicejin001@163.com, Lu, Shijian⁴ (AUTHOR) hcshi@usst.edu.cn, Jin, Jing^1,5 (AUTHOR), Tontiwachwuthikul, Paitoon⁶ (AUTHOR) paitoon@uregina.ca

Publikováno v: Catalysts (2073-4344). Nov2024, Vol. 14 Issue 11, p779. 23p.

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis

Autor: Kf, Laserson, Le, Thorpe, Leimane V, Weyer K, Cd, Mitnick, Riekstina V, Zarovska E, Ml, Rich, Hamish Fraser, Alarcón E, Jp, Cegielski, Grzemska M, Gupta R, Espinal M

Publikováno v: Europe PubMed Central

Globally it is estimated that 273000 new cases of multidrug-resistant tuberculosis (MDR-TB, resistance to isoniazid and rifampicin) occurred in 2000. To address MDR-TB management in the context of the DOTS strategy, the World Health Organization and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6e0b5c68160707e8f3fb911e37cba3c6
https://pubmed.ncbi.nlm.nih.gov/15971391

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study.

Autor: Baranda, Joaquina C.¹ (AUTHOR) jbaranda@kumc.edu, Robbrecht, Debbie² (AUTHOR), Sullivan, Ryan³ (AUTHOR), Doger, Bernard⁴ (AUTHOR), Santoro, Armando^5,6 (AUTHOR), Barve, Minal⁷ (AUTHOR), Grob, Jean‐Jacques⁸ (AUTHOR), Bechter, Oliver⁹ (AUTHOR), Vieito, Maria¹⁰ (AUTHOR), de Miguel, Maria Jose¹¹ (AUTHOR), Schadendorf, Dirk¹² (AUTHOR), Johnson, Melissa¹³ (AUTHOR), Pouzin, Clemence¹⁴ (AUTHOR), Cantalloube, Cathy¹⁴ (AUTHOR), Wang, Rui¹⁵ (AUTHOR), Lee, Jooyun¹⁶ (AUTHOR), Chen, Xiaofei¹⁶ (AUTHOR), Demers, Brigitte¹⁷ (AUTHOR), Amrate, Amele¹⁷ (AUTHOR), Abbadessa, Giovanni¹⁶ (AUTHOR)

Publikováno v: CTS: Clinical & Translational Science. Jun2024, Vol. 17 Issue 6, p1-17. 17p.